| Safety and Efficacy Study of DAV132 in Healthy Volunteers (NCT02176005) | Da Volterra | 2014-03-01 |
| A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions (NCT02081950) | Chemi S.p.A. | 2014-03-01 |
| Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation (NCT02159248) | Orlando Health, Inc. | 2014-03-01 |
| CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) (NCT02274584) | Peking University | 2014-03-01 |
| Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes (NCT02687152) | Karolinska Institutet | 2014-03-01 |
| Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects (NCT02084199) | Lakefront Biotherapeutics NV | 2014-03-01 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients (NCT02576093) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2014-03-01 |
| ADSC Injections for Pain Management of Osteoarthritis in the Human Knee Joint (NCT02357485) | Fodor, Peter B, M.D. | 2014-03-01 |
| Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants. (NCT02107885) | Daiichi Sankyo | 2014-03-01 |
| A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland (NCT02004418) | AHS Cancer Control Alberta | 2014-03-01 |
| Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer (NCT02079324) | Genexine, Inc. | 2014-03-01 |
| Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee (NCT02139319) | Galderma R&D | 2014-03-01 |
| To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers (NCT02056392) | AstraZeneca | 2014-03-01 |
| Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069 (NCT01890148) | AstraZeneca | 2014-03-01 |
| Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects (NCT02112942) | Merck Sharp & Dohme LLC | 2014-03-01 |
| Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects (NCT02122692) | H. Lundbeck A/S | 2014-03-01 |
| The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine (NCT02115958) | Fuda Cancer Hospital, Guangzhou | 2014-03-01 |
| Single Ascending Dose Study of PRX002 in Healthy Subjects (NCT02095171) | Prothena Biosciences Limited | 2014-03-01 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus (NCT02000700) | Janssen Research & Development, LLC | 2014-03-01 |
| Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants (NCT02079545) | Janssen Research & Development, LLC | 2014-03-01 |
| Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain (NCT02084511) | Boehringer Ingelheim | 2014-03-01 |
| Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants (NCT02109484) | PATH | 2014-03-01 |
| Nicotine Patch - Bioequivalence Study (NCT02089308) | Pierre Fabre Medicament | 2014-03-01 |
| Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease (NCT01559051) | Ageless Regenerative Institute | 2014-03-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers (NCT02111330) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2014-03-01 |
| A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers (NCT01918202) | Pfizer | 2014-03-01 |
| Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects (NCT02127034) | Astellas Pharma Europe B.V. | 2014-03-01 |
| Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers (NCT02101216) | Cellceutix Corporation | 2014-03-01 |
| Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses (NCT02087813) | Stanford University | 2014-03-01 |
| A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 (NCT02042248) | Cynthia L Gay, MD | 2014-03-01 |
| A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model (NCT01965600) | Pfizer | 2014-03-01 |
| Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA) (NCT02095548) | Biosplice Therapeutics, Inc. | 2014-03-01 |
| Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors (NCT02078843) | Insel Gruppe AG, University Hospital Bern | 2014-03-01 |
| MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function (NCT02050815) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2014-03-01 |
| Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing (NCT02091076) | Chulalongkorn University | 2014-03-01 |
| An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing (NCT02023047) | RDD Pharma Ltd | 2014-03-01 |
| Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection (NCT02095444) | S-Evans Biosciences Co., Ltd. | 2014-03-01 |
| Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (NCT02038842) | ANRS, Emerging Infectious Diseases | 2014-03-01 |
| Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults (NCT02034500) | GSK Vaccines Institute For Global Health S.r.l. | 2014-03-01 |
| Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients (NCT02098512) | New York Medical College | 2014-03-01 |
| A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome (NCT01906307) | La Jolla Pharmaceutical Company | 2014-03-01 |
| Visual Sputum Suctioning System Tests in Mechanically Ventilated Patients (NCT02116491) | First Affiliated Hospital of Chongqing Medical University | 2014-03-01 |
| Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer (NCT02489916) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2014-03-01 |
| Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults (NCT02099994) | University of Oxford | 2014-03-01 |
| Pharmacokinetics of rFVIIIFc at Two Vial Strengths (NCT02083965) | Bioverativ Therapeutics Inc. | 2014-03-01 |
| Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease (NCT02166489) | Royan Institute | 2014-03-01 |
| Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia (NCT02079844) | Takeda | 2014-03-01 |
| Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine (NCT02057315) | Achelios Therapeutics | 2014-03-01 |
| Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy (NCT02032316) | Adva-Tec | 2014-03-01 |
| Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo (NCT02097147) | Forest Laboratories | 2014-03-01 |
| Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) (NCT02195089) | BioLeaders Corporation | 2014-03-01 |
| A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males (NCT02072993) | AstraZeneca | 2014-03-01 |
| ABX464 First in Man Study (NCT02792686) | Abivax S.A. | 2014-03-01 |
| To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects (NCT02063204) | AstraZeneca | 2014-03-01 |
| A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant (NCT02078674) | Novavax | 2014-03-01 |
| The Clinical Study of Acute Pancreatitis Treated by TongFuSan (NCT02204189) | Beijing Friendship Hospital | 2014-03-01 |
| Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects (NCT02082808) | ViiV Healthcare | 2014-03-01 |
| The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study (NCT01901887) | Medical University of South Carolina | 2014-03-01 |
| A Phase I Study of AG-348 in Healthy Volunteers (NCT02108106) | Agios Pharmaceuticals, Inc. | 2014-03-01 |
| Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects (NCT02449005) | Aristotle University Of Thessaloniki | 2014-03-01 |
| CART-19 Immunotherapy in Mantle Cell Lymphoma (NCT02081937) | Chinese PLA General Hospital | 2014-03-01 |
| Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects. (NCT02616770) | SolAeroMed Inc. | 2014-03-01 |
| Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia (NCT02100839) | LipimetiX Development, LLC | 2014-03-01 |
| Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use (NCT02158117) | Norwegian University of Science and Technology | 2014-03-01 |
| Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3) (NCT02058095) | Mayo Clinic | 2014-03-01 |
| Fecal Microbiota Transplantation in Pediatric Patients (NCT02108821) | Children's Mercy Hospital Kansas City | 2014-03-01 |
| Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention (NCT02015494) | VaxInnate Corporation | 2014-03-01 |
| Safety Study of Vx006 Vaccine in Solid Tumor Patients (NCT02289196) | Vaxon Biotech | 2014-03-01 |
| Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation (NCT02074839) | Institut de Recherches Internationales Servier | 2014-03-01 |
| Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS) (NCT02071199) | Noveome Biotherapeutics, formerly Stemnion | 2014-03-01 |
| A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects (NCT02093390) | Millennium Pharmaceuticals, Inc. | 2014-03-01 |
| Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (NCT02018419) | Mirror Biologics, Inc. | 2014-03-01 |
| Impact of Endogenous E2 on SSI and GH Rebound (NCT02026973) | Mayo Clinic | 2014-03-01 |
| A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) (NCT02477306) | Genuine Research Center, Egypt | 2014-03-01 |
| Effect of Opicapone at Steady State on Warfarin Pharmacokinetics (NCT02305030) | Bial - Portela C S.A. | 2014-03-01 |
| Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma (NCT01689870) | Ludwig Institute for Cancer Research | 2014-03-01 |
| Relative Bioavailability For Palbociclib Formulations (NCT02083640) | Pfizer | 2014-03-01 |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors (NCT02038738) | Ochsner Health System | 2014-03-01 |
| Investigation of A-ECM for the Correction of Soft Tissue Defects (NCT01992315) | Aegeria Soft Tissue LLC | 2014-03-01 |
| Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020 (NCT02068053) | Bristol-Myers Squibb | 2014-03-01 |
| A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria (NCT02044198) | University of Oxford | 2014-03-01 |
| Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP (NCT01939067) | Children's Hospital of Philadelphia | 2014-03-01 |
| Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies (NCT02044861) | Advanced Cancer Therapeutics | 2014-03-01 |
| A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects (NCT02174510) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2014-03-01 |
| Drug Interaction Statin (NCT02089061) | Bristol-Myers Squibb | 2014-03-01 |
| A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2) (NCT02070289) | Pfizer | 2014-03-01 |
| Omega-3 Fatty Acids to Combat Sarcopenia (NCT02103842) | Mayo Clinic | 2014-03-01 |
| Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer (NCT01934634) | US Oncology Research | 2014-03-01 |
| Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects (NCT02094521) | Novo Nordisk A/S | 2014-03-01 |
| Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02057770) | Washington University School of Medicine | 2014-02-28 |
| Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt) (NCT02065401) | Shire | 2014-02-28 |
| A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors (NCT02107963) | National Cancer Institute (NCI) | 2014-02-28 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025) (NCT02007070) | Merck Sharp & Dohme LLC | 2014-02-28 |
| A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer (NCT01983501) | Seagen Inc. | 2014-02-28 |
| Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme (NCT01934361) | Novartis Pharmaceuticals | 2014-02-28 |
| A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (NCT02070510) | Novo Nordisk A/S | 2014-02-27 |
| Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT02058641) | GlaxoSmithKline | 2014-02-26 |
| A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects (NCT02064348) | Novo Nordisk A/S | 2014-02-26 |
| A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors (NCT01999972) | Pfizer | 2014-02-26 |
| Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population (NCT01877421) | U.S. Army Medical Research and Development Command | 2014-02-25 |